Comparing Sprintec vs Tri-Sprintec
| Sprintec | Tri-Sprintec |
|
|---|
| Sprintec (ethinyl estradiol / norgestimate) | Tri-Sprintec (ethinyl estradiol / norgestimate) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Abnormal Uterine Bleeding, Endometriosis, Ovarian Cysts, Birth Control, Gonadotropin Inhibition. Sprintec may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Acne, Abnormal Uterine Bleeding, Endometriosis, Ovarian Cysts, Birth Control, Gonadotropin Inhibition. Tri-Sprintec may also be used for purposes not listed in this medication guide. |
Related suggestions Birth Control
Abnormal Uterine Bleeding
Endometriosis
Ovarian Cysts
|
|||||||||||||||
| More about Sprintec (ethinyl estradiol / norgestimate) | More about Tri-Sprintec (ethinyl estradiol / norgestimate) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Sprintec has an average rating of 5.5 out of 10 from a total of 1295 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 36% reported a negative effect. |
Tri-Sprintec has an average rating of 5.4 out of 10 from a total of 840 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 38% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Lower cost generic approved | Lower cost generic approved | ||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Sprintec prices |
View all Tri-Sprintec prices |
||||||||||||||||
| Dosage Forms Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other ethinyl estradiol / norgestimate brands include: Estarylla, Femynor, Mili, Mono-Linyah, Nymyo, Previfem, Tri Femynor, Tri-Estarylla, Tri-Linyah, Tri-Lo-Estarylla, Tri-Lo-Linyah, Tri-Lo-Marzia, Tri-Lo-Mili, Tri-Lo-Sprintec, Tri-Mili, Tri-Nymyo, Tri-Previfem, Tri-Sprintec, Tri-VyLibra, Tri-Vylibra Lo, VyLibra View more | Other ethinyl estradiol / norgestimate brands include: Estarylla, Femynor, Mili, Mono-Linyah, Nymyo, Previfem, Sprintec, Tri Femynor, Tri-Estarylla, Tri-Linyah, Tri-Lo-Estarylla, Tri-Lo-Linyah, Tri-Lo-Marzia, Tri-Lo-Mili, Tri-Lo-Sprintec, Tri-Mili, Tri-Nymyo, Tri-Previfem, Tri-VyLibra, Tri-Vylibra Lo, VyLibra View more | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 466 drugs are known to interact with Sprintec:
|
A total of 466 drugs are known to interact with Tri-Sprintec:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
|
||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.